Symptomatic networks in suicide attempt and reattempt: Relevance of psychiatric comorbidity
- PMID: 39791330
- PMCID: PMC11795427
- DOI: 10.1192/j.eurpsy.2024.1807
Symptomatic networks in suicide attempt and reattempt: Relevance of psychiatric comorbidity
Abstract
Background: One of the most relevant risk factors for suicide is the presence of previous attempts. The symptomatic profile of people who reattempt suicide deserves attention. Network analysis is a promising tool to study this field.
Objective: To analyze the symptomatic network of patients who have attempted suicide recently and compare networks of people with several attempts and people with just one at baseline.
Methods: 1043 adult participants from the Spanish cohort "SURVIVE" were part of this study. Participants were classified into two groups: single attempt group (n = 390) and reattempt group (n = 653). Different network analyses were carried out to study the relationships between suicidal ideation, behavior, psychiatric symptoms, diagnoses, childhood trauma, and impulsivity. A general network and one for each subgroup were estimated.
Results: People with several suicide attempts at baseline scored significantly higher across all clinical scales. The symptomatic networks were equivalent in both groups of patients (p > .05). Although there were no overall differences between the networks, some nodes were more relevant according to group belonging.
Conclusions: People with a history of previous attempts have greater psychiatric symptom severity but the relationships between risk factors show the same structure when compared with the single attempt group. All risk factors deserve attention regardless of the number of attempts, but assessments can be adjusted to better monitor the occurrence of reattempts.
Keywords: impulsivity; network analysis; suicide; suicide reattempt; trauma.
Conflict of interest statement
PAS has been a consultant to and/or has received honoraria or grants from Adamed, Alter Medica, Angelini Pharma, CIBERSAM, Ethypharm Digital Therapy, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Johnson & Johnson, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas and Servier. AGP has received grants and served as a consultant, advisor, or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Alter, Angelini, Novartis, Rovi, Takeda, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. NR contract is co-funded by the Instituto de Salud Carlos III, with file code CD23/00088, by virtue of Resolution of the Direction of the Instituto de Salud Carlos III, O.A., M.P. of December 13, 2023, awarding the Sara Borell and “Co-funded by the European Union” Contracts. IG has received grants and has served as a consultant, advisor or CME speaker for the following entities (unrelated to the present work): ADAMED, Angelini, Casen Recordati, Esteve, Ferrer, Gedeon Richter, Janssen Cilag, Lundbeck, Lundbeck-Otsuka, Luye, SEI Healthcare, Viatris outside the submitted work. She also receives royalties from Oxford University Press, Elsevier, Editorial Médica Panamericana. The remaining authors have no conflicts to declare.
Figures
References
-
- World Health Organization. Suicide, https://www.who.int/news-room/fact-sheets/detail/suicide; 2024 [accessed 01 October 2024].
-
- de la Torre-Luque A, Perez-Diez I, Pemau A, Martinez-Ales G, Borges G, Perez-Sola V, Ayuso-Mateos JL. Suicide mortality in Spain during the COVID-19 pandemic: Longitudinal analysis of sociodemographic factors. Eur Neuropsychopharmacol. 2024;82:29–34. doi: 10.1016/j.euroneuro.2024.02.006. - DOI - PubMed
-
- Martínez-Alés G, Szmulewicz A, López-Cuadrado T, Morrison CN, Keyes KM, Susser ES. Suicide following the COVID-19 pandemic outbreak: variation across place, over time, and across sociodemographic groups. A systematic integrative review. Curr Psychiatry Rep. 2023;25(7):283–300. doi: 10.1007/s11920-023-01427-7. - DOI - PMC - PubMed
-
- World Health Organization. Suicide prevention: a global imperative. 2014.
